Mechanisms and strategies to overcome PD-1/PD-L1 blockade resistance in triple-negative breast cancer

X Chen, L Feng, Y Huang, Y Wu, N Xie - Cancers, 2022 - mdpi.com
Simple Summary Breast cancer is the most prevalent malignancy in women. With the
improvement of medical treatment, breast cancer has become one of the solid tumors with …

[HTML][HTML] The potential role and status of IL-17 family cytokines in breast cancer

X Song, C Wei, X Li - International immunopharmacology, 2021 - Elsevier
Breast cancer (BC) is currently the most common malignant tumor of women in the world. At
present, the development of BC is accelerating and showing a younger trend, which may be …

Presentation and characteristics of breast cancer in young women under age 40

X Hu, KS Myers, ET Oluyemi, M Philip, A Azizi… - Breast Cancer Research …, 2021 - Springer
Purpose Although uncommon, breast cancer is the leading cause of cancer death in young
women. There are limited studies on the presentation and characteristics of breast cancer in …

Psychological issues in breast cancer survivors confronted with motherhood: Literature review and a call to action

VE Di Mattei, G Perego, P Taranto, M Mazzetti… - Frontiers in …, 2023 - frontiersin.org
Breast cancer is currently the most common cancer among women worldwide; in 15–25% of
cases, patients are premenopausal at the time of diagnosis, and 50% of women desire …

Molecular mechanisms and therapeutic applications of huaier in breast cancer treatment

K Luo, L Zhou, Z Wu, Y Tian, J Jiang… - Frontiers in …, 2024 - frontiersin.org
Breast cancer is one of the most common female malignant tumors today and represents a
serious health risk for women. Although the survival rate and quality of life of patients with …

Fertility after cancer: risks and successes

C Di Tucci, G Galati, G Mattei, A Chinè, A Fracassi… - Cancers, 2022 - mdpi.com
Simple Summary Approximately one million new cases of cancer are diagnosed in women
of reproductive age every year. In the last few decades, advances in early diagnosis and …

The prognostic and clinical value of tumor-associated macrophages in patients with breast cancer: A systematic review and meta-analysis

C Wang, Y Lin, H Zhu, Y Zhou, F Mao, X Huang… - Frontiers in …, 2022 - frontiersin.org
Background The prognostic and clinical value of tumor-associated macrophages (TAMs) in
patients with breast cancer (BCa) remains unclear. We conducted the current meta-analysis …

Discovery of imidazopyridine-pyrazoline-hybrid structure as SHP-1 agonist that suppresses phospho-STAT3 signaling in human breast cancer cells

MH Yang, G Sethi, A Ravish, AK Mohan… - Chemico-Biological …, 2023 - Elsevier
Signal transducer and activator of transcription 3 (STAT3) promotes breast cancer
malignancy and controls key processes including proliferation, differentiation, and survival in …

Identification of the upregulation of MRPL13 as a novel prognostic marker associated with overall survival time and immunotherapy response in breast cancer

H Ye, N Zhang - Computational and Mathematical Methods in …, 2021 - Wiley Online Library
Mitochondrial ribosomal protein (MRPL) genes have been reported to participate in many
cellular processes, such as cell proliferation, apoptosis, and cell cycle. Meanwhile, the …

MiR-491-5p, as a tumor suppressor, prevents migration and invasion of breast cancer by targeting ZNF-703 to regulate AKT/mTOR pathway

J Guo, C Luo, Y Yang, J Dong, Z Guo… - Cancer Management …, 2021 - Taylor & Francis
Background Large amounts of microRNAs (miRNAs) have been reported to be aberrantly
expressed in malignant cancers. MiR-491-5p makes a significant contribution to the …